The presence of circulating TF-bearing microparticles has been reported in patients with cancer-associated thrombosis [99], venous thromboembolism [100], cardiac bypass surgery [101], Behҫet’s disease [102] and sepsis [103]. This evidence concerns the gene TF and deep vein thrombosis.